We were therefore surprised that parents reported fewer behaviors to intentionally elevate blood glucose levels and less worry about hypoglycemia overnight when their children transitioned from Basal-IQ to Control-IQ technology, as both systems lower insulin delivery in response to predicted hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.